Genetics: 2-Hit Model Flashcards

1
Q

What is the sporadic tumor model?

A

assumes that the patient starts out with 2 normal copies of the the tumor suppressor gene (TSG) and all malignant changes will occur as somatic mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the first and second “hits” to genes?

A

each hit is an independent mutational event that renders one allele nonfunctional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In sporadic tumors, what is the risk to family members?

A

nothing - because each mutation/hit was somatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the major difference in hereditary vs. sporadic tumors?

A

in sporadic tumors, the TSG hits are somatic only and not passed on; in hereditary tumors/cancers, the individual inherits a first hit and thus every cell in the body is heterozygous for a nonfunctional TSG allele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In a person with hereditary cancer, where does the second hit to TSG occur?

A

Within the tumor cells only, hence the development of cancerous proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The majority of hereditary cancers segregate through families as ____ ____. with ____ penetrance.

A

autosomal dominant; reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How would an individual with an inherited nonfunctional TSG allele not develop cancer?

A

by inheriting one hit (nonfunctional allele) and [somehow] avoiding the second hit needed to develop a tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or false: cancer families are not at risk for sporadic tumors; any tumor they develop wouldn’t be sporadic since they are already heterozygous for the nonfunctional TSG alleles.

A

False - cancer families are STILL at risk for sporadic tumors since these are somatic mutations that occur (randomly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mutation rate like in many cancers?

A

High

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Acquired [cancerous] somatic mutations will be passed on to where?

A

to its own daughter cells via clonal expansion only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a constitutional mutation?

A

mutation (cancerous) that occurs in all cells of the body, including germline and somatic; can be inherited r new mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In the case of hereditary cancers, a constitutional mutation confers a ____ risk of cancer.

A

high - because it’s in all cells and includes inherited mutation AND multiple acquired mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a driver mutation?

A

mutations in “cancer genes” that confers growth advantage through effects on a critical pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Typically, there are ____ driver mutations per tumor.

A

multiple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a passenger mutation?

A

mutation in cancer cells that confers no apparent growth advantage; these random mutations are carried along by clonal expansion; “along for the ride”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

True or false: an evolving tumor is homogenous with respect to genotype of the cells comprising the tumor.

A

False - an evolving tumor is genetically heterogenous

17
Q

What is the relationship between rounds of tumor cell division and acquired mutations?

A

more rounds of cell division = more acquired mutations

18
Q

Do advanced malignancies exhibit heterogenous or homogenous genomic instability?

A

heterogenous

19
Q

What are the 2 broad classes of cancer genes?

A
  1. oncogenes - when on they promote growth; mutated to gain of function
  2. TSG - when on they restrict growth; mutated to loss of function
20
Q

RB1 and NF1 are ____ ____ TSGs that when mutated can lead to ____ and ____, respectively.

A

cell cycle; retinoblastoma; neurofibromatosis type 1

21
Q

MLH1/MSH2/MSH6 are ____ ____ TSGs that when function is lost can lead to ____ and ____ respectively.

A

DNA repair; Lynch syndrome; Breast & Ovarian cancer

22
Q

TP53 is an ____ ___ (gene type) that when mutated to loss of function can lead to ____ syndrome.

A

apoptotic TSG; Li-Fraumini

23
Q

Tumor suppressor genes segregate as AD disease with reduced penetrance. The phenotype is ____ at the patient level and ____ at the tumor level.

A

dominant; recessive
Dominant at pt level because while most cells remain heterozygous, the tumor phenotype is present.
Recessive at the tumor level because it takes 2 mutations to create the tumor phenotype.

24
Q

What are 3 mechanisms for acquiring the second hit in sporadic cancers?

A
  1. loss of heterozygosity (ie, microdeletion, mitotic nondisjunction, mitotic recombination)
  2. point mutation (typical LOF mutation)
  3. epigenetic silencing (normal allele is methylated)
25
Q

Is penetrance usually high in familial cases of hereditary cancer?

A

yes

26
Q

What are some characteristics that accompany hereditary cancers?

A
  • multiple affected family members
  • risk of multiple primary tumors
  • increased risk of other types of cancer
  • earlier age of onset
  • may be other phenotypic features in addition to cancer
  • reduced penetrance
27
Q

Describe 3 genetic mechanisms for activation of oncogenes.

A
  1. point mutation
  2. somatically acquired reciprocal translocation
  3. gene amplification
28
Q

Somatically acquired reciprocal translocation of the ABL and BCR genes, creating a fusion gene, occurs between which 2 chromosomes?

A

9 and 22

29
Q

What does the fusion protein encoded by the BCR-ABL fusion gene do?

A

it’s a constitutively expressed tyrosine kinase that confers potential for malignant transformation and result in CML

30
Q

____ is a drug used to treat CML and it specifically targets the fusion protein (ABL-BCR).

A

Imatinib

31
Q

What is gene amplification?

A

abnormal copy number variants of a proto-oncogene, causing the protein product to be hyperexpressed and leading to malignancies

32
Q

What are two types of gene amplifications seen in oncogene amplification?

A
  1. HSR - homogenously staining regions; visible in chromosomes as an extra non-banded region (picture long adjacent repeated gene)
  2. DM - double minutes; extrachromosomal genes that are circular without centromeres or telomeres and segregate randomly at cell division
33
Q

When is gene amplification constitutional?

A

Never. Just like outlawing guns or cheese.

34
Q

HER2 is a member of the ____ family.

A

EGFR

35
Q

What 2 drugs target HER2 to treat HER2-positive cancers?

A

Herceptin

Kadcyla